MoonLake Immunotherapeutics

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC MLTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/13/2026

Shares

74,162

Value ($000)

1,382

Weight

0.0%

2023 Q3 - 2026 Q1 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/13/2026	1,382	0.0%	74,162	3/31/2026
2025 Q2	8/14/2025	905	0.0%	19,164	6/30/2025
2025 Q1	5/19/2025	1,711	0.0%	43,804	3/31/2025
2024 Q4	2/14/2025	2,287	0.0%	42,236	12/31/2024
2024 Q3	11/14/2024	1,806	0.0%	35,814	9/30/2024
2024 Q2	8/14/2024	802	0.0%	18,234	6/30/2024
2024 Q1	5/15/2024	765	0.0%	15,231	3/31/2024
2023 Q4	2/14/2024	920	0.0%	15,231	12/31/2023
2023 Q3	11/13/2023	865	0.0%	15,178	9/30/2023